RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R10006 | Allitinib tosylate (Synonyms: AST-1306 (TsOH))/897383-62-9 Free base | AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM |
| R10042 | CO1686; Rociletinib | Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibit |
| R10087 | AZD9291 | Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi |
| R10126 | WZ4002 | WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with |
| R10152 | Neratinib; HKI272 | Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5 |
| R10233 | Tyrphostin A9;Tyrphostin 9; Malonoben | Tyrphostin 9 is firstly designed as an EGFR inhibitor with IC50 of 460 μM, but i |
| R10253 | Dacomitinib，PF299804 | Dacomitinib (PF299804, PF299) is a potent, irreversible pan-ErbB inhibitor, most |
| R10254 | AZD9291 Mesylate | AZD-9291 is a potent and selective mutated forms EGFR inhibitor(Exon 19 deletion |
| R10259 | AG490 | AG-490 (Tyrphostin B42) is an inhibitor of EGFR with IC50 of 0.1 μM in cell-free |
| R10449 | Gefitinib; ZD1839 | Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 |
| R10569 | Pelitinib | Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM |
| R10585 | AZD3759 | AZD3759 is a potent, oral active, central nervous system-penetrant, EGFR inhibit |
| R10699 | AG18 | AG-18 inhibits EGFR with IC50 of 35 μM. |
| R10711 | AG-1517 | PD153035 HCl is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 |
| R10818 | Varlitinib; ARRY 543 | Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with |
| R10880 | Lapatinib (GW572016; GW2016) | Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 |
| R10900 | CL-387785 ; EKI-785 | CL-387785(EKI785; WAY-EKI 785) is an irreversible inhibitor of EGFR with IC50 of |
| R10904 | Irbinitinib; ARRY-380; ONT-380 | Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor with IC5 |
| R10930 | Icotinib | Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM, including th |
| R11536 | PD168393 | PD168393 is an irreversible EGFR inhibitor with IC50 of 0.70 nM, irreversibly al |
| R11603 | WZ3146 | WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and |
| R190306 | AST2818 mesylate | AST2818 mesylate is an EGFR inhibitor. |
| R2032681 | BMS599626 | BMS-599626 (AC480) is a selective and orally bioavailable HER1 and HER2 inhibito |
| R2032738 | AV412 | AV-412 free base (MP-412 free base) is an EGFR inhibitor with IC50s of 0.75, 0.5 |
Page 1 / Total 1 FirstPrevNextLastGoto
